DexCom (Germany) Performance
| DC4 Stock | 78.36 0.11 0.14% |
On a scale of 0 to 100, DexCom holds a performance score of 15. The firm shows a Beta (market volatility) of -0.24, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning DexCom are expected to decrease at a much lower rate. During the bear market, DexCom is likely to outperform the market. Please check DexCom's maximum drawdown, semi variance, accumulation distribution, as well as the relationship between the potential upside and skewness , to make a quick decision on whether DexCom's price patterns will revert.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, DexCom unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 818.2 M | |
| Free Cash Flow | 53.3 M |
DexCom |
DexCom Relative Risk vs. Return Landscape
If you would invest 6,338 in DexCom Inc on October 9, 2024 and sell it today you would earn a total of 1,498 from holding DexCom Inc or generate 23.64% return on investment over 90 days. DexCom Inc is generating 0.3783% of daily returns and assumes 1.9318% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than DexCom, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
DexCom Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DexCom Inc, and traders can use it to determine the average amount a DexCom's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1958
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DC4 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.93 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.2 actual daily | 15 85% of assets perform better |
Based on monthly moving average DexCom is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DexCom by adding it to a well-diversified portfolio.
DexCom Fundamentals Growth
DexCom Stock prices reflect investors' perceptions of the future prospects and financial health of DexCom, and DexCom fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DexCom Stock performance.
| Current Valuation | 42.38 B | |||
| Price To Book | 25.96 X | |||
| Price To Sales | 17.58 X | |||
| Revenue | 2.45 B | |||
| EBITDA | 377.9 M | |||
| Total Debt | 1.7 B | |||
| Cash Flow From Operations | 442.5 M | |||
| Total Asset | 4.86 B | |||
About DexCom Performance
Assessing DexCom's fundamental ratios provides investors with valuable insights into DexCom's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the DexCom is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about DexCom Inc performance evaluation
Checking the ongoing alerts about DexCom for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DexCom Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating DexCom's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate DexCom's stock performance include:- Analyzing DexCom's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DexCom's stock is overvalued or undervalued compared to its peers.
- Examining DexCom's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DexCom's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DexCom's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DexCom's stock. These opinions can provide insight into DexCom's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for DexCom Stock Analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.